- The members of the American Association for Cancer Research have elected MSKCC’s Charles L. Sawyers, M.D., as their president-elect for 2012-2013.
- The New England Journal of Medicine published an MSKCC study that found that high-dose chemotherapy improved the rate of survival for patients with three specific genetic mutations, compared with standard-dose chemo.
- Researchers from MSKCC and St. Jude Children’s Research Hospital have identified the first gene mutation associated with a chronic and often fatal form of neuroblastoma that typically strikes adolescents and young adults.